ADMA Annual ROE
-19.67%
+25.29%+56.25%
31 December 2023
Summary:
As of January 22, 2025, ADMA annual return on equity is -19.67%, with the most recent change of +25.29% (+56.25%) on December 31, 2023. During the last 3 years, it has risen by +112.71% (+85.14%). ADMA annual ROE is now -100.29% below its all-time high of 6833.33%, reached on June 1, 2010.ADMA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMA Quarterly ROE
39.59%
+17.16%+76.50%
30 September 2024
Summary:
As of January 22, 2025, ADMA quarterly return on equity is 39.59%, with the most recent change of +17.16% (+76.50%) on September 30, 2024. Over the past year, it has increased by +55.98% (+341.55%). ADMA quarterly ROE is now -99.44% below its all-time high of 7100.00%, reached on September 30, 2010.ADMA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMA ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +56.3% | +341.6% |
| 3 y3 years | +85.1% | +176.3% |
| 5 y5 years | +91.0% | +176.3% |
ADMA ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +68.5% | at high | +160.2% |
| 5 y | 5-year | at high | +90.6% | at high | +122.8% |
| alltime | all time | -100.3% | +96.3% | -99.4% | +101.3% |
ADMA Biologics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 39.59%(+76.5%) |
| June 2024 | - | 22.43%(-1000.8%) |
| Mar 2024 | - | -2.49%(-87.1%) |
| Dec 2023 | -19.67%(-56.3%) | -19.32%(+17.9%) |
| Sept 2023 | - | -16.39%(-46.4%) |
| June 2023 | - | -30.56%(-18.0%) |
| Mar 2023 | - | -37.29%(-28.2%) |
| Dec 2022 | -44.96%(-28.0%) | -51.90%(-13.6%) |
| Sept 2022 | - | -60.04%(-2.0%) |
| June 2022 | - | -61.26%(-6.9%) |
| Mar 2022 | - | -65.78%(+2.1%) |
| Dec 2021 | -62.46%(-52.8%) | -64.40%(-15.8%) |
| Sept 2021 | - | -76.47%(-4.3%) |
| June 2021 | - | -79.91%(-4.9%) |
| Mar 2021 | - | -84.07%(-20.3%) |
| Dec 2020 | -132.38%(-37.0%) | -105.49%(-3.2%) |
| Sept 2020 | - | -109.00%(+0.2%) |
| June 2020 | - | -108.74%(-13.9%) |
| Mar 2020 | - | -126.30%(-27.3%) |
| Dec 2019 | -210.08%(-4.0%) | -173.63%(-6.6%) |
| Sept 2019 | - | -185.81%(+3.6%) |
| June 2019 | - | -179.42%(-16.6%) |
| Mar 2019 | - | -215.05%(+12.6%) |
| Dec 2018 | -218.77%(-10.3%) | -191.01%(+4.1%) |
| Sept 2018 | - | -183.55%(-5.9%) |
| June 2018 | - | -194.99%(-33.9%) |
| Mar 2018 | - | -295.07%(-11.3%) |
| Dec 2017 | -243.95% | -332.56%(-52.4%) |
| Sept 2017 | - | -698.14%(-7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2017 | - | -753.64%(-200.6%) |
| Mar 2017 | - | 748.88%(-61.0%) |
| Dec 2016 | 437.83%(-183.2%) | 1921.44%(-220.6%) |
| Sept 2016 | - | -1593.72%(+148.0%) |
| June 2016 | - | -642.65%(+71.5%) |
| Mar 2016 | - | -374.80%(+44.7%) |
| Dec 2015 | -526.23%(+331.7%) | -258.98%(+31.8%) |
| Sept 2015 | - | -196.56%(+30.3%) |
| June 2015 | - | -150.80%(+18.2%) |
| Mar 2015 | - | -127.57%(-1.3%) |
| Dec 2014 | -121.91%(+21.7%) | -129.27%(-16.0%) |
| Sept 2014 | - | -153.98%(-9.4%) |
| June 2014 | - | -169.93%(-16.2%) |
| Mar 2014 | - | -202.69%(+0.2%) |
| Dec 2013 | -100.19%(-35.4%) | -202.23%(-12.1%) |
| Sept 2013 | - | -230.05%(+47.9%) |
| June 2013 | - | -155.59%(+81.0%) |
| Mar 2013 | - | -85.98%(+21.1%) |
| Dec 2012 | -154.98%(-107.6%) | -70.97%(+47.4%) |
| Sept 2012 | - | -48.15%(+101.4%) |
| June 2012 | - | -23.91%(+51.2%) |
| Mar 2012 | - | -15.81%(-98.9%) |
| Dec 2011 | - | -1505.00%(-51.2%) |
| Sept 2011 | - | -3085.71%(+188.3%) |
| June 2011 | 2038.46%(-70.2%) | -1070.27%(+34.4%) |
| Mar 2011 | - | -796.43%(-135.9%) |
| Dec 2010 | - | 2220.00%(-68.7%) |
| Sept 2010 | - | 7100.00%(+27.5%) |
| June 2010 | - | 5566.67% |
| June 2010 | 6833.33% | - |
FAQ
- What is ADMA Biologics annual return on equity?
- What is the all time high annual ROE for ADMA Biologics?
- What is ADMA Biologics annual ROE year-on-year change?
- What is ADMA Biologics quarterly return on equity?
- What is the all time high quarterly ROE for ADMA Biologics?
- What is ADMA Biologics quarterly ROE year-on-year change?
What is ADMA Biologics annual return on equity?
The current annual ROE of ADMA is -19.67%
What is the all time high annual ROE for ADMA Biologics?
ADMA Biologics all-time high annual return on equity is 6833.33%
What is ADMA Biologics annual ROE year-on-year change?
Over the past year, ADMA annual return on equity has changed by +25.29% (+56.25%)
What is ADMA Biologics quarterly return on equity?
The current quarterly ROE of ADMA is 39.59%
What is the all time high quarterly ROE for ADMA Biologics?
ADMA Biologics all-time high quarterly return on equity is 7100.00%
What is ADMA Biologics quarterly ROE year-on-year change?
Over the past year, ADMA quarterly return on equity has changed by +55.98% (+341.55%)